These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

345 related articles for article (PubMed ID: 2619982)

  • 1. The Positive and Negative Syndrome Scale (PANSS): rationale and standardisation.
    Kay SR; Opler LA; Lindenmayer JP
    Br J Psychiatry Suppl; 1989 Nov; (7):59-67. PubMed ID: 2619982
    [No Abstract]   [Full Text] [Related]  

  • 2. Pimozide treatment of the negative schizophrenic syndrome: an open trial.
    Feinberg SS; Kay SR; Elijovich LR; Fiszbein A; Opler LA
    J Clin Psychiatry; 1988 Jun; 49(6):235-8. PubMed ID: 3288615
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [A four-dimensional model of chronic schizophrenia based on the factorial structure of the Positive and Negative Syndrome Scale (PANSS). A study of a group of 153 chronic schizophrenic patients and comparison with the factorial structure of the BPRS].
    Loas G; Noisette C; Legrand A; Delahousse J
    Encephale; 1997; 23(1):10-8. PubMed ID: 9172962
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Psychometric properties of PANSS (Positive and Negative Syndrome Scale) in the French version in a sample of schizophrenic patients].
    Lançon C; Auquier P; Llorca PM; Martinez JL; Bougerol T; Scotto JC
    Encephale; 1997; 23(1):1-9. PubMed ID: 9172961
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Mortality among chronic schizophrenic patients: a prospective 14-year follow-up study of 150 schizophrenic patients].
    Loas G; Azi A; Noisette C; Yon V
    Encephale; 2008 Jan; 34(1):54-60. PubMed ID: 18514151
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Manchester Scale. A standardised psychiatric assessment for rating chronic psychotic patients.
    Hyde CE
    Br J Psychiatry Suppl; 1989 Nov; (7):45-8. PubMed ID: 2619981
    [No Abstract]   [Full Text] [Related]  

  • 7. Diagnostic validity of assessment scales for depression in patients with schizophrenia.
    Kim SW; Kim SJ; Yoon BH; Kim JM; Shin IS; Hwang MY; Yoon JS
    Psychiatry Res; 2006 Sep; 144(1):57-63. PubMed ID: 16904189
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [The PANSS (Positive And Negative Symptom) Scale].
    Guelfi JD
    Encephale; 1997 Apr; 23 Spec No 2():35-8. PubMed ID: 9273305
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Subjective experiences and the psychopathological dimensions in schizophrenia.
    Yon V; Loas G; Brien D
    Psychiatry Res; 2005 Nov; 137(1-2):93-102. PubMed ID: 16213596
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of the use of the positive and negative syndrome scale-excited component as a criterion for administration of p.r.n. medication.
    Chaichan W
    J Psychiatr Pract; 2008 Mar; 14(2):105-13. PubMed ID: 18360196
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Standardized assessment of psychopathology by relatives of mentally disordered patients. Preliminary results of using the positive and negative syndrome scale to compare schizophrenic and affective disorders.
    Nitsche I; Kallert TW
    Psychopathology; 2007; 40(4):242-53. PubMed ID: 17440287
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Thai version of the Positive and Negative Syndrome Scale (PANSS) for schizophrenia: criterion validity and interrater reliability.
    Nilchaikovit T; Uneanong S; Kessawai D; Thomyangkoon P
    J Med Assoc Thai; 2000 Jun; 83(6):646-51. PubMed ID: 10932491
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Core factors of schizophrenia structure based on PANSS and SAPS/SANS results. Discerning and head-to-head comparisson of PANSS and SASPS/SANS validity].
    Masiak M; Loza B
    Psychiatr Pol; 2004; 38(5):795-808. PubMed ID: 15523927
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Comparison of 2 depression scales and their relationship with negative and akinetic symptoms in stabilized schizophrenic patients].
    Langlois-Thery S; Dollfus S; Lesieur P; Petit M
    Encephale; 1994; 20(5):487-93. PubMed ID: 7828511
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pimozide versus chlorpromazine in chronic schizophrenia: a 52 week double-blind study of maintenance therapy.
    Wilson LG; Roberts RW; Gerber CJ; Johnson MH
    J Clin Psychiatry; 1982 Feb; 43(2):62-5. PubMed ID: 7035441
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Revisiting the 5 dimensions of the Positive and Negative Syndrome Scale.
    Levine SZ; Rabinowitz J
    J Clin Psychopharmacol; 2007 Oct; 27(5):431-6. PubMed ID: 17873671
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Negative symptoms, depression, anxiety and alexithymia in DSM III-R schizophrenic patients].
    Nkam I; Langlois-Thery S; Dollfus S; Petit M
    Encephale; 1997; 23(4):267-72. PubMed ID: 9417392
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [InSka (Intentionality Scale)--a new psychopathometric instrument for the detection of schizophrenic residual symptoms].
    Mundt C; Fiedler P; Pracht B; Rettig R
    Nervenarzt; 1985 Mar; 56(3):146-9. PubMed ID: 3990882
    [No Abstract]   [Full Text] [Related]  

  • 19. Stability in schizophrenia symptoms over time: findings from the Mount Sinai Pilgrim Psychiatric Center Longitudinal Study.
    Reichenberg A; Rieckmann N; Harvey PD
    J Abnorm Psychol; 2005 Aug; 114(3):363-72. PubMed ID: 16117573
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Validation of positive and negative symptom scale (PANSS) in a sample of Spanish schizophrenic patients].
    Peralta Martín V; Cuesta Zorita MJ
    Actas Luso Esp Neurol Psiquiatr Cienc Afines; 1994; 22(4):171-7. PubMed ID: 7810373
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.